Gastric diseases, including peptic ulcer disease and gastric cancer, affect 10% of the world's population and are largely due to chronic Helicobacter pylori infection [1] [2] [3] . Species differences in embryonic development and architecture of the adult stomach make animal models suboptimal for studying human stomach organogenesis and pathogenesis 4 , and there is no experimental model of normal human gastric mucosa. Here we report the de novo generation of threedimensional human gastric tissue in vitro through the directed differentiation of human pluripotent stem cells. We show that temporal manipulation of the FGF, WNT, BMP, retinoic acid and EGF signalling pathways and three-dimensional growth are sufficient to generate human gastric organoids (hGOs). Developing hGOs progressed through molecular and morphogenetic stages that were nearly identical to the developing antrum of the mouse stomach. Organoids formed primitive gastric gland-and pit-like domains, proliferative zones containing LGR5-expressing cells, surface and antral mucous cells, and a diversity of gastric endocrine cells. We used hGO cultures to identify novel signalling mechanisms that regulate early endoderm patterning and gastric endocrine cell differentiation upstream of the transcription factor NEUROG3. Using hGOs to model pathogenesis of human disease, we found that H. pylori infection resulted in rapid association of the virulence factor CagA with the c-Met receptor, activation of signalling and induction of epithelial proliferation. Together, these studies describe a new and robust in vitro system for elucidating the mechanisms underlying human stomach development and disease.
The human stomach contains a complex, three-dimensional glandular epithelium that is organized into two distinct functional domains 5 : the fundus (corpus), which is the major source of peptidases and acid, and the antrum (pylorus) that comprises a concentration of mucussecreting cells and hormone-producing endocrine cells. Unlike other endoderm organs, little is known about signalling pathways regulating gastric development and, to our knowledge, no one has yet generated gastric tissues from human pluripotent stem cells [6] [7] [8] . Therefore, to direct differentiation of stem cells into complex, three-dimensional gastric tissue, we needed to identify the signalling pathways that regulate several critical stages of early stomach development including: (1) posterior foregut specification and formation of the anterior gut tube; (2) gastric specification and patterning into the fundus or antrum; and (3) epithelial growth, morphogenesis, and differentiation into gastric cell lineages.
We first differentiated pluripotent stem cells into definitive endoderm 9 , which in vivo is then patterned along the anterior-to-posterior axis and transformed into a gut tube consisting of Sox2 1 foregut in the anterior and Cdx2 1 mid-hindgut in the posterior as shown in control mouse embryos (Fig. 1a ). We previously demonstrated that WNT3A and FGF4 synergize to induce the morphogenesis of gut tube-like structures expressing the posterior marker CDX2 (refs 6,10). To generate foregut, from which the stomach derives, we aimed to stimulate gut tube morphogenesis with WNT and FGF while inhibiting their ability to promote posterior fate. We found that WNT/FGF require BMP activity to initiate posterior gene expression, consistent with the known role of BMP as a posterior-defining factor [11] [12] [13] . Specifically, inhibiting BMP signalling with the antagonist noggin (NOG) resulted in repression of the posterior marker CDX2, activation of the foregut marker SOX2 and assembly of three-dimensional foregut spheroids ( Fig. 1b-d and Extended Data Fig. 1 ). Foregut spheroid morphogenesis was a robust process using both human embryonic stem (ES) cell and human induced pluripotent stem (iPS) cell lines ( Fig. 1c, d and Extended Data Fig. 2 ). Thus, we identified a new epistatic relationship between WNT, FGF and BMP in which all three pathways cooperate to promote a mid-hindgut fate, but WNT and FGF act separately from BMP to drive morphogenesis of gut tube structures.
The subsequent events of stomach development in vivo are posterior patterning of the foregut and specification of the fundic and antral domains of the stomach. To direct spheroids into a posterior foregut fate (indicated in mouse embryos by co-expression of Sox2 and Hnf1b; Fig. 1e ), we focused on retinoic acid signalling given its role in development of posterior-foregut-derived organs [14] [15] [16] . Exposing definitive endoderm to retinoic acid for 24 h on the final day (day 5-6) of the patterning/ spheroid generation stage resulted in the formation of SOX2/HNF1b 1 posterior foregut spheroids ( Fig. 1f , g and Extended Data Fig. 3 ). In the mouse embryo, the posterior foregut undergoes morphogenesis and is subdivided into the Sox2 1 /Pdx1 2 fundus, Sox2/Pdx1 1 antrum, Pdx1/ Ptf1a 1 pancreas, and Pdx1/Cdx2 1 duodenum ( Fig. 2b ). To promote three-dimensional growth and morphogenesis, we transferred posterior foregut spheroids to a semisolid matrix and found that an additional 72 h of retinoic acid (day 6-9) caused a .100-fold increase in PDX1 messenger RNA levels while maintaining high SOX2 expression ( Fig. 2c, d ), indicating specification into antrum. Importantly, the retinoic acid treatment did not promote a pancreatic fate 8 , since expression of the pancreasspecific marker PTF1A (ref. 17) was not induced (Fig. 2d ). These data demonstrate that the combination of retinoic acid signalling with threedimensional growth efficiently direct posterior foregut spheroids into a SOX2/PDX1 1 epithelium indicative of a gastric antrum fate.
The next stages of stomach development are characterized by growth of a pseudo-stratified epithelium into an elaborate glandular epithelium. We explored various growth conditions and found that high concentrations of EGF (100 ng ml 21 ) were sufficient to promote robust outgrowth of SOX2/PDX1 1 spheroids into hGOs. Over the course of 3-4 weeks, spheroids (,100 mm in diameter) underwent marked expansion into organoids (2-4 mm in diameter) containing a complex columnar epithelium ( Fig. 2e ). EGF was required for the initial outgrowth of foregut spheroids as well as their expansion and morphogenesis at later stages (Extended Data Fig. 4c ), revealing a new role for EGF receptor signalling during embryonic stomach formation that is temporally distinct from its postnatal function as a trophic factor 18, 19 . hGO development was remarkably similar to in vivo stomach organogenesis. At early stages (embryonic day (E)12-14 in mouse and day-13 hGOs), both epithelia were pseudo-stratified, contained mitotic nuclei concentrated towards the apical surface indicating interkinetic nuclear migration, and were appropriately polarized and contained deep elaborations of atypical protein kinase C (aPKC 1 ) apical membrane (Extended Data Fig. 4b ) 20 . At later stages (E16.5-postnatal day (P)12 in mouse, day-13-34 hGOs), the in vivo antrum transformed into a simple columnar epithelium exhibiting a highly structured organization, and the hGOs underwent similar folding and formed immature pit and gland domains ( Fig. 2e , f and Extended Data Fig. 4a ).
Molecular markers that define the developing mouse antrum in vivo showed analogous temporal and spatial expression patterns in developing hGOs. At early stages (E12-14 in mouse and 13-day hGOs) the transcription factors SOX2, PDX1, GATA4 and KLF5 were all co-expressed in the immature, pseudo-stratified epithelium of the antrum (Extended Data Fig. 4 ). However, at later stages (E18-P12 in mouse and day-34 hGOs), SOX2 was downregulated as the epithelium formed glands and pits, whereas the expression of the other factors was maintained. On the basis of these data, the day-13 hGOs represent a developmental stage similar to the E12-14 mouse antrum, whereas day-34 hGOs are more comparable to the late-fetal/early-postnatal antrum. Furthermore, the early spheroid mesoderm expanded during organoid differentiation, expressed mesenchymal transcription factors including FOXF1 and BAPX1 (ref. 21) , and differentiated into VIM 1 submucosal fibroblasts and a smaller number of ACTA2 1 subepithelial myofibroblasts (Extended Data Figs 4 and 5). Thus, we conclude that hGOs recapitulate normal embryonic development, and that the molecular and morphogenetic processes that occur during antrum development are conserved between rodents and humans.
RNA-sequencing (RNA-seq) analysis showed that day-34 organoids and human fetal stomach tissue share a very similar transcriptional profile, which is distinct from human fetal intestine (Extended Data Fig. 6b ). The antral region in the embryonic and postnatal stomach can be distinguished from the fundus by its expression of PDX1 ( Fig. 2f ), as well as by a concentration of certain cell types. Antral cell types include mucous cells, which secrete the protective mucus lining, and several endocrine lineages that regulate gastrointestinal physiology and metabolic homeostasis ( Fig. 3a ). By day 27, hGOs robustly expressed numerous transcripts that mark differentiated antral cell types (Extended Data Fig. 6a ), including surface mucous cells (MUC5AC, TFF1/3 and GKN1) and antral gland cells (TFF2), but not cell types associated with the fundus/corpus such as parietal cells (ATP4A/B) and chief cells (MIST1 (also known as BHLHA15)), or intestinal goblet cells (MUC2). At day 34, histological analysis revealed that both mucous cell lineages were abundant in the hGOs (Fig. 3b-f ): surface mucous cells with tall columnar morphology and apical MUC5AC expression; and MUC6 1 antral gland cells that were concentrated towards the base of the glands. Parietal cells (ATP4B) were undetectable in the hGOs, and the lack of fundus cell types coupled with ubiquitous PDX1 expression are consistent with an antral identity ( Fig. 2 and Extended Data Fig. 4 ). The adult antrum contains pure glands with only antral lineages and mixed glands containing 
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both antral and fundic lineages 22 . However, PDX1 expression remains restricted to antral cell types even in mixed glands 22 , suggesting the possibility that PDX1 1 progenitor cells only give rise to antrum-specific cell types postnatally. Thus, we conclude that the PDX1-expressing hGOs are a pure antrum/pylorus cell population. The antrum also contains LGR5-expressing stem cells 23 and specialized endocrine cells. At day 34, hGOs contained a SOX9 1 proliferative progenitor zone as well as LGR5 1 cells at the base of the glands (Fig. 3d-f and Fig. 4a ), identified using a transgenic LGR5-eGFP reporter (containing enhanced green fluorescent protein) stem-cell line (Extended Data Fig. 7 ). hGOs contained a complete spectrum of endocrine cells normally found in the antrum that were positive for the hormones gastrin, ghrelin, somatostatin and serotonin ( Fig. 3g) . Notably, we observed that high levels of EGF repressed expression of the proendocrine transcription factor NEUROG3 (refs 24,25) and the formation of endocrine cells, whereas low concentrations of EGF (10 ng ml 21 ) supported endocrine cell formation (Extended Data Fig. 8b-d ). Transient overexpression of NEUROG3 was sufficient to overcome the endocrine inhibitory effect of EGF, resulting in robust differentiation of gastric endocrine cells (Extended Data Fig. 8e-g) . In summary, hGOs have a high degree of cellular complexity that rivals that of the human antrum, they can be experimentally manipulated, and they therefore represent the first in vitro model of human stomach development.
Clinical evidence indicates that predominant colonization of the antrum has an important role in H. pylori-mediated disease 26, 27 . Thus, we tested whether hGOs could be used to model the pathophysiological response of the human stomach to H. pylori. To mimic the normal hostpathogen interface, we microinjected H. pylori directly into the lumen of the epithelium and measured epithelial signalling and proliferation. Within 24 h, bacteria were observed tightly associated with the hGO epithelium ( Fig. 4a and Extended Data Fig. 9b ) and we observed robust epithelial responses including phosphorylation of c-Met 28 (Fig. 4b and Extended Data Fig. 9c ) and a twofold increase in epithelial cell proliferation (Fig. 4c ). The H. pylori virulence factor CagA plays a pivotal role in the aetiology of disease. Consistent with published studies 29 , we observed that CagA translocated into organoid epithelial cells and formed a complex with the c-Met receptor (Fig. 4b ). Furthermore, the epithelial response was lost when hGOs were injected with a strain of H. pylori lacking CagA, demonstrating the dependence on CagA for H. pylorimediated human pathogenesis. Thus, the pathophysiological response of hGOs makes them an unprecedented model for elucidating the initiating events of human gastric disease mediated by H. pylori. E10.5 Fig. 2a ) demonstrated sequential activation of SOX2 at day 6 (posterior foregut (FG) endoderm), followed by induction of PDX1 at day 9 (presumptive antrum). Day-9 antral spheroids had a 500-fold increase in SOX2 and a 10,000-fold increase in PDX1 relative to day-3 definitive endoderm (DE 
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In summary, hGOs represent the first, to our knowledge, human gastric tissue fully derived in vitro (summarized in Extended Data Figure 10 ) and are one of the most physiologically complex micro-organ systems yet established. The hGOs undergo normal stages of in vivo differentiation, comprise an array of cell types that constitute the normal antral epithelium, and contain a complex three-dimensional organization. We have used hGOs as an in vitro system to identify signalling mechanisms that regulate human stomach development and physiology, and we have modelled the pathophysiological response of the gastric epithelium to H. pylori. Thus, hGOs should present new opportunities for drug discovery and modelling the early stages of gastric disease, including cancer. Moreover, this is, to our knowledge, the first three-dimensional production of a human embryonic foregut and represents a promising starting point for the three-dimensional generation of other foregut organ tissues including fundus, lungs and pancreas.
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Pluripotent stem-cell culture. Human ES cell lines WA01 (H1) and WA09 (H9) were obtained from WiCell. ES and iPS cell lines were maintained as colonies in feeder-free conditions on human-ES-cell-qualified Matrigel (BD Biosciences) in mTesR1 media (Stem Cell Technologies). Cells were routinely passaged every 4 days with dispase (Invitrogen). Differentiation of definitive endoderm. For differentiation, pluripotent stem cells were plated as single cells in a Matrigel-coated 24-well dish using accutase (Stem Cell Technologies), at a density of 150,000 cells per well in mTesR1 with ROCK inhibitor Y-27632 (10 mM; Stemgent). On the next day, stem cells were differentiated to definitive endoderm as previously described 9, 30 . Cells were exposed to activin A (100 ng ml 21 ; Cell Guidance Systems) for 3 days in RPMI 1640 media (Invitrogen) containing increasing concentrations of 0%, 0.2% and 2.0% defined FBS (dFBS; Invitrogen). In addition, BMP4 (50 ng ml 21 ; R&D Systems) was added on the first day of definitive endoderm induction. Endoderm patterning and foregut spheroid generation. After definitive endoderm induction, cells were cultured in RPMI 1640 media with 2.0% dFBS and the indicated combinations of growth factors and/or chemical agonist: WNT3A (500 ng ml 21 ; R&D Systems); CHIR99021 (2 mM; Stemgent); FGF4 (500 ng ml 21 ; R&D Systems); and NOG (200 ng ml 21 ; R&D Systems). The media was changed every day. After three days, the combination of WNT3A (or CHIR99021), FGF4 and NOG resulted in floating foregut spheroids in the culture wells. To induce a posterior fate in foregut endoderm, retinoic acid (2 mM; Sigma Aldrich) was added on the third day of WNT/FGF/NOG treatment.
Three-dimensional culture of gastric organoids. The spheroids were transferred to a three-dimensional in vitro culture system as previously described 6, 10 . In brief, spheroids were collected, resuspended in 50 ml Matrigel (BD Biosciences), and plated in a three-dimensional droplet. After Matrigel was allowed to solidify for 10-15 min in a tissue culture incubator, spheroids were overlaid with gut media: Advanced DMEM/F12 with N2 (Invitrogen), B27 (Invitrogen), L-glutamine, 10 mM HEPES, penicillin/streptomycin, and EGF (100 ng ml 21 ; R&D Systems). For the first 3 days, retinoic acid and NOG were added to the gut media. Media was replaced every 3-4 days, as necessary. At day 20, organoids were collected and re-plated in fresh Matrigel at a dilution of ,1:12.
Generation of doxycycline-inducible NEUROG3 stem-cell line. To generate the overexpression construct, human NEUROG3 complementary DNA (Dana-Farber/ Harvard Cancer Center DNA Resource Core; clone HsCD00345898) was cloned into pInducer20 lentiviral vector (provided by T. Westbrook 31 ) using Gateway Cloning (Invitrogen) methods. High-titre lentiviral particles were produced by the CCHMC Viral Vector Core. H1 ES cells were dissociated with Accutase, plated as a single-cell suspension in mTesR1 with 10 mM Y-27632, and exposed to lentivirus for 4 hours. mTesR1 was replaced daily and after 2 days, G418 (200 mg ml 21 ) was added to the media to select for integrated clones. G418-resistant cells were maintained in antibiotic indefinitely, but were otherwise cultured and passaged normally. When the culture reached an attenuance (D) at 600 nm of 0.5, recombineering proteins were induced by incubation at 42 uC for 20 min. After induction, cells were spun at 5,000g, washed in ice-cold water, and resuspended in 200 ml ice-cold 10% glycerol. The recombination cassette consisted of eGFP-FRT-PGKgb2-neo/kan-FRT, a 50-base-pair (bp) homology region in LGR5, and a 20-bp homology region to peGFP-PGKneo. The homology regions were selected to replace the initiator methionine of LGR5 with that of eGFP followed by a bovine growth hormone polyadenylation signal and an FRT-flanked bifunctional kanamycin/G418 resistance cassette. The recombination cassette was electroporated into SW105 cells, and cells were selected on plates with chloramphenicol and kanamycin (kan; 50 mg ml 21 ). Clones were analysed for properly targeted LGR5 BAC by PCR (primer sequences listed in Methods) and confirmed by sequencing and nucleofected into single-cell suspensions of H9 ES cells using the Amaxa Human Stem Cell Nucleofector Starter Kit. Cells were selected for in G418 (200 ng ml 21 ) for 2 weeks. G418-resistant cells were maintained in antibiotic indefinitely. All primer sequences are listed in the Methods. Generation and characterization of iPS cell lines. Primary human foreskin fibroblasts (HFFs) were cultured from neonatal human foreskin tissue and obtained from two donors through the Department of Dermatology, University of Cincinnati, and were a gift from S. Wells. HFFs were cultured in fibroblast media consisting of DMEM (Invitrogen) supplemented with 10% FCS (Hyclone) and used for reprogramming between passages 5 and 8. EBNA1/OriP-based episomal plasmids pCLXE-hOct3/4-shp53, pCLXE-hSox2-Klf4, pCLXE-hLmyc-Lin28 and pCLXE-GFP used for this study were previously described 33 and obtained from Addgene (ID numbers: 27077, 27078, 27080 and 27082, respectively). The optimized Human Dermal Fibroblast Nucleofector Kit (VPD-1001; Lonza) was used for transfection of HFFs with episomal plasmids. In brief, for each transfection 1 3 10 6 HFFs were pelleted by centrifugation at 200g for 10 min at room temperature, resuspended in 100 ml Nucleofector Solution and nucleofected with 1.25 mg each episomal plasmid (program U20). Cells from two transfections (2 3 10 6 total cells) were replated in a 10-cm tissue culture plate in fibroblast media, and cultured at 37 uC/5% CO 2 . Six days after transfection, 4.5 3 10 5 HFFs were replated in fibroblast media in a gelatin-coated 10-cm dish containing 1.07 3 10 6 irradiated mouse embryonic fibroblasts. Starting on day 7 post-transfection, cells were fed daily with DMEM/F12 media supplemented with 20% knockout serum replacement, 1 mM L-glutamine, 0.1 mM bmercaptoethanol, 0.1 mM non-essential amino acids, and 4 ng ml 21 basic FGF (all from Invitrogen). Approximately two weeks later, discrete colonies with ES-celllike morphology were manually excised and replated in mTeSR1 media (Stem Cell Technologies) in tissue culture dishes coated with ES-cell-qualified Matrigel (Becton Dickinson). Following adaptation to mTeSR1/Matrigel culture, iPS cells that maintained robust proliferation and ES-cell-like morphology with minimal spontaneous differentiation were expanded for characterization including testing for mycoplasma (MycoAlert kit, Lonza) and cryopreservation. Standard metaphase spreads and G-banded karyotypes were determined by the CCHMC Cytogenetics Laboratory. For teratoma formation, iPS cells from three wells of a six-well dish were combined and gently resuspended in ice-cold DMEM/ F12. Immediately before injection, Matrigel was added to a final concentration of ,33% and cells were injected subcutaneously into immunocompromised non-obese diabetic-severe combined immunodeficient (NOD scid gamma (NSG)) mice with IRB approval (3D06043). Tumours formed within 6-12 weeks. Excised teratomas were fixed, embedded in paraffin, and sections were stained with haematoxylin and eosin for histological examination. Taqman hPSC Scorecard Assay (Life Technologies) was performed according to manufacturer's instructions. Helicobacter pylori infection. Helicobacter pylori strain G27 (ref. 34 ) and a mutant G27 strain lacking CagA (DCagA) 35 were grown on blood agar plates consisting of Columbia Agar Base (Fisher Scientific), 5% horse blood (Colorado Serum Company), 5 mg ml 21 vancomycin and 10 mg ml 21 trimethoprim as described previously 36 . For organoid injections, H. pylori were resuspended in brucella broth at a concentration of 1 3 10 9 bacteria per ml and loaded onto the Nanoject II (Drummond) microinjector apparatus. Approximately 200 nl (containing 2 3 10 5 bacteria) was injected directly in the lumen of each organoid, and injected organoids were cultured for 24 h. Brucella broth was injected as a negative control. Before all infection experiments, antibiotics were removed from the organoid growth medium. Immunofluorescent staining. All tissues were fixed in 4% paraformaldehyde for either 1 h at room temperature for frozen processing or overnight at 4 uC for paraffin processing. Control mouse embryonic and postnatal tissues were obtained from time plugged CD-1 female mice with IRB approval (3D06043). For frozen sections, tissue was protected in 30% sucrose overnight at 4 uC, then embedded in OCT (Tissue-Tek), and cut at 10 mm. For paraffin sections, tissue was processed through a graded ethanol series, followed by xylene, and then embedded in paraffin and cut at 7 mm. Tissue culture cells were fixed for 15 min at room temperature and stained directly. For staining, frozen slides were thawed to room temperature and rehydrated in PBS, while paraffin slides were deparaffinized and subjected to antigen retrieval. Slides were blocked in 5% normal donkey serum (Jackson Immuno Research) in PBS plus 0.5% Triton-X for 30 min at room temperature. Primary antibodies (listed in the Methods) were diluted in blocking buffer and incubated overnight at 4 uC. Slides were washed in PBS and incubated with secondary antibody for 1 h at room temperature, and coverslips were mounted using Fluoromount-G (Southern Biotech). Confocal images were captured on a Nikon A1Rsi inverted confocal microscope. Transmission electron microscopy imaging. Organoids were fixed in 2% glutaraldehyde plus 2% paraformaldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) for 16 h at 4 uC. Organoids were then washed using 0.1 M sodium cacodylate buffer followed by a 1-h incubation using 4% osmium tetroxide, washed and then dehydrated using 25-100% ethanol (series of dilutions), embedded using propylene oxide/LX112. Blocks were sectioned (150 nm) and stained with 2% uranyl acetate followed by lead citrate. Tissue was visualized using a Hitachi transmission electron microscope equipped with an AMT Image Capture Engine version 5.42.366 and MicroFIRE by Optronics camera using AMTV600 digital camera software. RNA isolation and qPCR. Total RNA was isolated from tissues using the Nucleospin RNA II kit (Machery-Nagel). Reverse transcription was performed from 100 ng RNA using Superscript VILO cDNA Synthesis Kit (Invitrogen) according to the manufacturer's protocol. qPCR was performed using Quantitect SybrGreen Master Mix (Qiagen) on a CFX-96 Real-time PCR Detection System (BioRad). Analysis was performed using the DDC t method. PCR primers were designed using sequences from qPrimerDepot (http://primerdepot.nci.nih.gov) and are listed in the Methods. a, Lineage diagram that summarizes the patterning effects of noggin and retinoic acid in the formation of both anterior and posterior foregut endoderm (aFG and pFG, respectively). b, Bright-field images show that retinoic acid increased the number of spheroids that are produced from foregut monolayer cultures. c, A lower power image of Fig. 1d showing immunofluorescent image of an E8.5, 14-somite stage embryo with Hnf1b protein localized to the posterior portion of the foregut. Boxed region of embryo is shown in Fig. 1d .
d, qPCR analysis of gene expression in foregut spheroids treated with retinoic acid. Posterior foregut markers HNF1B and HNF6 were robustly induced by 24-h exposure to retinoic acid. Although retinoic acid induced posterior foregut gene expression it did not induce expression of the posterior marker CDX2. *P , 0.05; Student's t-test; n 5 3 biological replicates per condition, data representative of 3 independent experiments. Scale bars, 1 mm (b) and 100 mm (c). Error bars represent s.d.
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Extended Data Figure 6 | Induction of genes during development of hGOs that mark specific differentiated antral cell types. a, qPCR analyses of cell lineage differentiation marker expression at several stages throughout the gastric organoid differentiation protocol (days 0, 3, 6, 9, 20, 27 and 34) and day-34 human intestinal organoids (hIO). Beginning at day 27, hGOs robustly induced genes expressed in differentiated cell types including surface mucous cells (MUC5AC, TFF1, TFF3 and GKN1) and antral gland cells (TFF2). hGOs do not upregulate the expression of markers found in fundic lineages such as parietal cells (ATP4A and ATP4B) and chief cells (MIST1) or intestinal goblet cells (MUC2). Expression levels are normalized to day-3 definitive endoderm cultures. n 5 3 biological replicates per time point. b, Muc5AC-expressing surface mucous cells in the late fetal (E18.5) mouse antrum are not yet confined to a pit region and are more broadly distributed through the antral epithelium. Furthermore, these pit cells exhibit high amounts of intracellular mucin staining, similar to day-34 hGOs. c, Global gene expression profiling of day-34 hGOs was performed using RNA-seq, and data were compared to published RNA-seq data sets from human tissues. Hierarchical clustering revealed that hGOs closely resemble human fetal stomach tissue but not human fetal intestine. Error bars represent s.d.
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